Depression Care in the United States

Abstract

Objective: To determine the prevalence and adequacy of depression care among different ethnic and racial groups in the United States. Design: Collaborative Psychiatric Epidemiology Surveys (CPES) data were analyzed to calculate nationally representative estimates of depression care. Setting: The 48 coterminous United States. Participants: Household residents 18 years and older (N=15 762) participated in the study. Main Outcome Measures: Past-year depression pharmacotherapy and psychotherapy using American Psychiatric Association guideline-concordant therapies. Depression severity was assessed with the Quick Inventory of Depressive Symptomatology Self-Report. Primary predictors were major ethnic/racial groups (Mexican American, Puerto Rican, Caribbean black, African American, and non-Latino white) and World Mental Health Composite International Diagnostic Interview criteria for 12-month major depressive episode. Results: Mexican American and African American individuals meeting 12-month major depression criteria consistently and significantly had lower odds for any depression therapy and guideline-concordant therapies despite depression severity ratings not significantly differing between ethnic/racial groups. All groups reported higher use of any past-year psychotherapy and guideline-concordant psychotherapy compared with pharmacotherapy; however, Caribbean black and African American individuals reported the highest proportions of this use. Conclusions: Few Americans with recent major depression have used depression therapies and guideline-concordant therapies; however, the lowest rates of use were found among Mexican American and African American individuals. Ethnic/racial differences were found despite comparable depression care need. More Americans with recent major depression used psychotherapy over pharmacotherapy, and these differences were most pronounced among Mexican American and African American individuals. This report underscores the importance of disaggregating ethnic/racial groups and depression therapies in understanding and directing efforts to improve depression care in the United States.

Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder

“…Most individuals with depression go untreated or undertreated. A recent large study in the USA found only 21 % of individuals in the sample with a diagnosis of MDD had received at least one form of APA guideline-concordant therapy in the previous year [36]. Clearly, more research is needed to refine our understanding of the best strategies for implementing guideline-based care [37], and improve the consistency of care provided for patients with MDD in busy, 'real-world' practices.…”

Indicators for Electroconvulsive Therapy among Patients Hospitalized for Depression

“…15 When black patients with depression do receive outpatient treatment, it is typically less intensive, of lower quality, and less commonly provided by a specialist. 16 Likewise, with few exceptions, the prevalence, incidence, and morbidity risk of depressive disorders are higher in women than in men, beginning at mid-puberty and persisting through adult life. 17 There appeared to be a higher frequency of cardiovascular risk factors in patients who underwent ECT.…”

A Comparison of Methods for Capturing Patient Preferences for Delivery of Mental Health Services to Low-Income Hispanics Engaged in Primary Care

“…[6][7][8] Federally-qualified health centers (FQHCs) provide an essential safety net for many underserved populations in the US; [9] they also face a number of challenges in providing primary care, mental health, and public health services responsive to their patients-i.e., patient-centered care.…”